These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37736725)
1. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study. Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725 [TBL] [Abstract][Full Text] [Related]
2. Gout patients have an increased risk of developing most cancers, especially urological cancers. Chen CJ; Yen JH; Chang SJ Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466 [TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study. Wang L; Du H; Sheng C; Dai H; Chen K Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801 [TBL] [Abstract][Full Text] [Related]
4. Global Burden of Urologic Cancers, 1990-2013. Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study. Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250 [TBL] [Abstract][Full Text] [Related]
6. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III. Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212 [TBL] [Abstract][Full Text] [Related]
7. An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus. Yeo J; Seo MS; Hwang IC; Shim JY Arch Iran Med; 2020 Sep; 23(9):614-620. PubMed ID: 32979908 [TBL] [Abstract][Full Text] [Related]
8. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study. Tran TT; Gunathilake M; Lee J; Kim J Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study. Zhang S; Wang D; Zhao J; Zhao H; Xie P; Zheng L; Sheng P; Yuan J; Xia B; Wei F; Zhang Z BMC Public Health; 2024 Jan; 24(1):233. PubMed ID: 38243159 [TBL] [Abstract][Full Text] [Related]
10. Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study. Jiang R; Li Z; Wang X; Cai H; Wu S; Chen S; Hu H Technol Health Care; 2023; 31(4):1235-1244. PubMed ID: 36617800 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank. Monroy-Iglesias MJ; Russell B; Crawley D; Allen NE; Travis RC; Perez-Cornago A; Van Hemelrijck M; Beckmann K Int J Cancer; 2021 Feb; 148(4):825-834. PubMed ID: 33405276 [TBL] [Abstract][Full Text] [Related]
12. [Metabolic syndrome components and renal cell cancer risk in Chinese males: a population-based prospective study]. Li X; Li N; Wen Y; Lyu ZY; Feng XS; Wei LP; Chen YH; Chen HD; Wang G; Chen SH; Ren JS; Shi JF; Cui H; Wu SL; Dai M; He J Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):638-643. PubMed ID: 32842279 [No Abstract] [Full Text] [Related]
13. Coffee and tea drinking and risk of cancer of the urinary tract in male smokers. Hashemian M; Sinha R; Murphy G; Weinstein SJ; Liao LM; Freedman ND; Abnet CC; Albanes D; Loftfield E Ann Epidemiol; 2019 Jun; 34():33-39. PubMed ID: 31023511 [TBL] [Abstract][Full Text] [Related]
14. Association of metabolic syndrome and the risk of bladder cancer: A prospective cohort study. Fang S; Liu Y; Dai H; Gao T; Zeng L; Sun R; Zheng Z; Yuan J; Xia B; Pan Y Front Oncol; 2022; 12():996440. PubMed ID: 36263231 [TBL] [Abstract][Full Text] [Related]
15. The association of metabolic syndrome score trajectory patterns with risk of all cancer types. Deng L; Liu T; Liu CA; Zhang Q; Song MM; Lin SQ; Wang YM; Zhang QS; Shi HP Cancer; 2024 Jun; 130(12):2150-2159. PubMed ID: 38462898 [TBL] [Abstract][Full Text] [Related]
16. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort. Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896 [TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study. Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397 [TBL] [Abstract][Full Text] [Related]
18. Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study. Chen LC; Yang HJ; Yu BH; Lee MS; Lin HY; Chiou WY; Liu DW; Hsu FC; Chew CH; Hung SK PLoS One; 2024; 19(3):e0300391. PubMed ID: 38536840 [TBL] [Abstract][Full Text] [Related]
19. Urologic cancer in Thailand. Lojanapiwat B Jpn J Clin Oncol; 2015 Nov; 45(11):1007-15. PubMed ID: 26355159 [TBL] [Abstract][Full Text] [Related]
20. Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants. Luo P; Xu W; Ye D; Chen W; Ying J; Liu B; Li J; Sun X; He Z; Wen C; Mao Y J Rheumatol; 2024 Apr; 51(4):360-367. PubMed ID: 38224984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]